CH623047A5 - - Google Patents
Download PDFInfo
- Publication number
- CH623047A5 CH623047A5 CH1089779A CH1089779A CH623047A5 CH 623047 A5 CH623047 A5 CH 623047A5 CH 1089779 A CH1089779 A CH 1089779A CH 1089779 A CH1089779 A CH 1089779A CH 623047 A5 CH623047 A5 CH 623047A5
- Authority
- CH
- Switzerland
- Prior art keywords
- radical
- formula
- carbon atoms
- compound
- lactone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/566,356 US3974146A (en) | 1975-04-09 | 1975-04-09 | Cyanolpoxy intermediates for prostaglandins and process for preparing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH623047A5 true CH623047A5 (US20050065096A1-20050324-C00039.png) | 1981-05-15 |
Family
ID=24262537
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH355676A CH620916A5 (US20050065096A1-20050324-C00039.png) | 1975-04-09 | 1976-03-22 | |
| CH1089879A CH621119A5 (US20050065096A1-20050324-C00039.png) | 1975-04-09 | 1979-12-07 | |
| CH1089779A CH623047A5 (US20050065096A1-20050324-C00039.png) | 1975-04-09 | 1979-12-07 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH355676A CH620916A5 (US20050065096A1-20050324-C00039.png) | 1975-04-09 | 1976-03-22 | |
| CH1089879A CH621119A5 (US20050065096A1-20050324-C00039.png) | 1975-04-09 | 1979-12-07 |
Country Status (15)
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2070990A (en) * | 1934-06-25 | 1937-02-16 | Shell Dev | Treatment of halogenated polyhydric alcohols |
| US2772295A (en) * | 1953-02-02 | 1956-11-27 | Eastman Kodak Co | Process of manufacturing esters of 3-substituted 2-furoic acids |
| US3426046A (en) * | 1965-10-22 | 1969-02-04 | Dow Chemical Co | Synthesis of epoxides from allylic sulfonium salts |
| US3711515A (en) * | 1970-11-27 | 1973-01-16 | Upjohn Co | Tricyclic lactone alkene or alkenyne |
| US3864387A (en) * | 1973-05-21 | 1975-02-04 | Upjohn Co | 5-Oxa phenyl-and phenoxy-substituted prostaglandin F{HD 1{301 {0 {B analogs |
-
1975
- 1975-04-09 US US05/566,356 patent/US3974146A/en not_active Expired - Lifetime
-
1976
- 1976-01-12 ZA ZA761534A patent/ZA761534B/xx unknown
- 1976-02-25 SE SE7602350A patent/SE424867B/xx not_active IP Right Cessation
- 1976-03-05 CA CA247,284A patent/CA1075251A/en not_active Expired
- 1976-03-08 MX MX000049U patent/MX3431E/es unknown
- 1976-03-10 GB GB9506/76A patent/GB1523212A/en not_active Expired
- 1976-03-10 GB GB40438/77A patent/GB1523213A/en not_active Expired
- 1976-03-22 CH CH355676A patent/CH620916A5/de not_active IP Right Cessation
- 1976-03-31 DE DE19762613701 patent/DE2613701A1/de active Granted
- 1976-04-02 JP JP51036151A patent/JPS6024104B2/ja not_active Expired
- 1976-04-07 HU HU76UO00000118A patent/HU173022B/hu not_active IP Right Cessation
- 1976-04-08 DK DK165376A patent/DK165376A/da not_active IP Right Cessation
- 1976-04-08 PL PL1976188594A patent/PL103085B1/pl unknown
- 1976-04-08 FR FR7610324A patent/FR2319638A1/fr active Granted
- 1976-04-08 NL NL7603695A patent/NL7603695A/xx not_active Application Discontinuation
- 1976-04-09 BE BE166026A patent/BE840597A/xx not_active IP Right Cessation
- 1976-11-26 FR FR7635645A patent/FR2319639A1/fr active Granted
-
1979
- 1979-06-13 SE SE7905211A patent/SE435508B/sv not_active IP Right Cessation
- 1979-12-07 CH CH1089879A patent/CH621119A5/de not_active IP Right Cessation
- 1979-12-07 CH CH1089779A patent/CH623047A5/de not_active IP Right Cessation
-
1983
- 1983-12-20 JP JP58239039A patent/JPS6021992B2/ja not_active Expired
- 1983-12-20 JP JP58239040A patent/JPS6036435B2/ja not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH626876A5 (US20050065096A1-20050324-C00039.png) | ||
| DE2538532C2 (de) | Verfahren zur Abtrennung von stereospezifischer Farnesylessigsäure oder deren Ester aus stereoisomeren Mischungen | |
| AT367747B (de) | Verfahren zur herstellung von optisch aktiven oder racemischen prostaglandinen und ihren salzen | |
| DE1768434A1 (de) | Verfahren zur Herstellung von Cyclopentylalkansaeuren | |
| DE69116541T2 (de) | Eine synthesemethode für prostaglandinderivate | |
| DE2539116C2 (de) | ω-Nor-cycloalkyl-13,14-dehydro-prostaglandine, Verfahren zu ihrer Herstellung sowie sie enthaltende pharmazeutische Mittel | |
| DE2550004C2 (de) | Thiaprostaglandine sowie Verfahren zu ihrer Herstellung | |
| EP0173142B1 (de) | Verfahren zur Herstellung von optisch aktiven Hydrochinonderivaten | |
| DE2611788C2 (de) | Fluorprostaglandine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel | |
| DE1949800C2 (de) | Neue Indanderivate und deren Herstellung | |
| CH623047A5 (US20050065096A1-20050324-C00039.png) | ||
| DE2328131C3 (de) | Neues Verfahren zur Herstellung von Prostaglandin-F↓2↓↓α↓ und seinen Analogen | |
| DE2429766A1 (de) | Verfahren zur herstellung von optisch aktiven bicyclischen lactondiolen und deren racemische gemische | |
| DE2825855C3 (de) | 15-substituierte-ι-Pentanorprostaglandin-derivate | |
| CH622020A5 (US20050065096A1-20050324-C00039.png) | ||
| EP0083335A1 (de) | Chirale, optisch aktive Verbindungen, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen für den Schutz funktioneller -OH, -SH, -NH-Gruppen, zur Racemattrennung, zur Herstellung optisch aktiver Imidoesterhydrochloride sowie optisch aktiver Ester, zur Herstellung optisch angereicherter Alkohole und zur Herstellung optisch aktiver Verbindungen durch asymmetrische Induktion | |
| WO1983001449A1 (en) | Method for the preparation of intermediary compounds of carbacyclin | |
| EP0008077B1 (de) | Neue Prostaglandinderivate in der Delta-2-PGF2 und Delta-2-PGE2-Reihe, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel | |
| DE2918747A1 (de) | Tricyclo- alpha , beta -ungesaettigte-ketone | |
| CH666895A5 (de) | Verfahren zur herstellung von aminocyclopentansaeuren und ihrer physiologisch annehmbaren salze und solvate. | |
| CH659472A5 (de) | Epoxycarbacyclinderivate, ihre herstellung und verwendung. | |
| DE2731459A1 (de) | Cyclohexan-analoge vom prostaglandin-typ, verfahren zu deren herstellung und diese enthaltende zusammensetzungen | |
| DE2739770C3 (de) | 19-Methyl-9-keto-15-hydroxy-prost-18-ensäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| CH617424A5 (US20050065096A1-20050324-C00039.png) | ||
| DE2703471A1 (de) | Zwischenprodukte zur herstellung, von prostaglandinen und prostaglandinanaloga und verfahren zu deren herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |